Journal
Influenza and Other Respiratory Viruses
Publication Date
6-1-2024
Volume
18
Issue
6
First Page
e13342
Document Type
Open Access Publication
DOI
10.1111/irv.13342
Rights and Permissions
Chung, J., Shirk, P., Gaglani, M., Mutnal, M., Nowalk, M., Moehling Geffel, K., House, S., Curley, T., Wernli, K., Kiniry, E., Martin, E., Vaughn, I., Murugan, V., Lim, E., Saade, E., Faryar, K., Williams, O., Walter, E., Price, A., Barnes, J., DaSilva, J., Kondor, R., Ellington, S. and Flannery, B. (2024), Late-Season Influenza Vaccine Effectiveness Against Medically Attended Outpatient Illness, United States, December 2022–April 2023. Influenza Other Respi Viruses, 18: e13342. https://doi.org/10.1111/irv.13342 Published 2024. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Chung, Jessie R; House, Stacey L; Curley, Tara; and et al., "Late-season influenza vaccine effectiveness against medically attended outpatient illness, United States, December 2022-April 2023." Influenza and Other Respiratory Viruses. 18, 6. e13342 (2024).
https://digitalcommons.wustl.edu/oa_4/5702
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
